Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Syntaxin Binding Protein 3 (STXBP3) (C-Term) Peptid

STXBP3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN8113316
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Syntaxin Binding Protein 3 (STXBP3) (C-Term) Peptid (ABIN8113316)

Target

STXBP3 (Syntaxin Binding Protein 3 (STXBP3))

Spezies

Human

Quelle

  • 7
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Verwendungszweck

    STXBP3 Peptide - C-terminal region

    Sequenz

    RSAEETFQLS RWTPFIKDIM EDAIDNRLDS KEWPYCSQCP AVWNGSGAVS
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-STXBP3 Antibody (ARP64530_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    STXBP3 (Syntaxin Binding Protein 3 (STXBP3))

    Hintergrund

    Background Information: Together with STX4 and VAMP2, STXBP3 may play a role in insulin-dependent movement of GLUT4 and in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes.

    Alternative Symbols: MUNC18-3, MUNC18C, PSP, UNC-18C

    Molekulargewicht

    68kDa

    Gen-ID

    6814

    NCBI Accession

    NP_009200

    UniProt

    O00186
Sie sind hier:
Chat with us!